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Abstract 
Background and Aim: Nanoparticle drug delivery has recently found a special place in medicine and treatment. 
Different nanoparticles have different capabilities and functions. Gold nanoparticles are one of the most widely used 
nanoparticles and have many uses in pharmaceuticals and medical purposes, including diagnostic, therapeutic, and 
imaging methods, and due to their unique characteristics, such as high contact surface area compared to volume. 
Gold nanoparticles have many advantages over other nanoparticles such as their neutral nature, stability, high 
diffusion property, non-toxicity, environmental compatibility, optical adjustment. Our goal is to synthesize and 
characterization gold nanoparticles with specific applications to produce the best delivery system of drugs to the 
asthmatic lung. 
Methods: Turkevich method has been used for the synthesis of gold nanoparticles and approving studies have been 
done.  
Results: The produced GNP has the average diameter 100-200 nm and the Z-average was 137.9 d.nm and in positive 
charge area. PDI for GNP was 0.358. 
Conclusion: In this study, we were able to produce the applicable gold nanoparticles for carrying drugs to asthmatic 
bronchi. Gold nanoparticles easily reach target cells due to their high dispersion power. Drug side effects are reduced 
when gold nanoparticles are used in conjunction with the drug for drug delivery purposes. 
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Introduction 
Asthma is a complex disease that is classified by 
differences in severity, the natural history of the 
disease, response to treatment, and its clinical signs 
include airways contraction and narrowing 
bronchial epithelium swelling and thickening, 
mucus secretion, coughing, wheezing, and 
breathlessness. For this reason, asthma is 
considered a chronic airway disorder (1). For some 
people, asthma is a major problem and interferes 
with their daily activities and lives, leading to 
severe and dangerous attacks. According to the 
World Health Organization, asthma is a rapidly 
progressive disease its economic and social 
pressures are greater than both TB and HIV. The 
high rates of death and disability caused by asthma 
have become serious public and social health 
concerns (2, 3). 
Symptoms and clinical manifestations of asthma 
include; chest pain, difficulty breathing, sleep 
disturbances, wheezing during exhaustion, frequent 
coughing. Exacerbation of asthma with respiratory 
triggers such as respiratory viral infections, 
allergens, airborne substances, such as dust mites, 
pollen, pet dander, mold spores, cold air, and 
smoking are usual asthma triggers. Having other 
allergic diseases such as atopic dermatitis, allergic 
rhinitis, urticaria, eczema, and also, overweight, 
being a smoker increase chance of asthma 
developing (1-3). Currently, the use of anti-asthma 
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drugs has significantly reduced asthma mortality. 
When drugs are used traditionally and routinely, 
larger amounts are often needed because the drug 
may not be fully and properly delivered to the target 
tissue and significant amounts may be metabolized 
before reaching the destination, and that is itself 
Excess amounts can cause side effects in the body. 
Recent advances in nanotechnology and the use of 
nanoparticles have led to the production of more 
effective drugs for asthma control. The side effects 
of drugs are minimized by the use of gold 
nanoparticles, and this substance also reduces the 
duration of the disease. Gold nanoparticles reach 
the target cells easily due to their high dispersion 
power (4). 
Nano drugs can be divided into two categories, 
traditional drugs that are improved by 
nanotechnology and new nano-drugs that use the 
nano-materials themselves as drugs (3). 
Nanoparticles are the carrier of genes, DNA, and 
RNA molecules that are either adsorbed on the 
surface of the nanoparticles or wrapped in the 
nanoparticles. Molecules such as specific ligands 
and monoclonal antibodies bind to the surface of 
the nanoparticles. After attaching target molecules 
to specific receptors on the cell surface, the 
nanoparticles enter it through cellular uptake thus 
safely and effectively deliver targeted therapeutic 
genes and drugs. For this reason, the selection and 
fabrication of nanocarriers are one of the most 
important issues in the treatment of diseases such as 
asthma at present (1, 3). 
GNPs are one of the most widely used nanoparticles 
and have many applications in pharmaceuticals and 
medical purposes, including diagnostic, therapeutic, 
and imaging modalities. Au NPs have unique 
properties, such as a high Specific surface area to 
particle volume, neutral nature, stability, high 
dispersibility, non-toxic, environmentally friendly, 
optical adjustable, in comparison with other 
nanoparticles. Gold nanoparticles are readily 
functionalized for binding to proteins, amino acids, 
DNA, carboxylic acids, thiols, disulfides, and 
aptamers are available. The side effects of drugs 
using gold nanoparticles are minimized and this 
substance significantly reduces the duration of the 
disease (1, 5, 6). In fact, the Au NPs can easily 
reach target cells because of their high dispersion 
power (5). In this study, we designed and produced 
gold nanoparticles to bind to a biomolecule.  
Methods 
Synthesis 
Gold (III) chloride trihydrate (HAuCl4) and tri-
sodium citrate were purchased (Merck, Germany). 
Synthesis of AuNPs was accomplished by the 
Turkevich method (7) which involves the reduction 
of tetra chloroaurate by tri-sodium citrate. Citrate 
anions play a dual role in this reaction, both as a 
reducing agent by transferring electrons to gold ions 
and then adsorbing citrate anions to the surface of 
the gold nanoparticle through the central 
carboxylate group and acting as a nanoparticle 
stabilizing agent. The repulsive effect between the 
citrate layers leads to the stability of the gold 
nanoparticle and the not formation of particle 
aggregation. In this work, we modified the 
Terkovich method to obtain AuNPs with diameters 
ranging from 100 to 200 nm, by controlling the 
ratio of reducing agent/stabilizing agent (tri-sodium 
citrate/gold). In brief, 7.5 mL of 0.001 molar 
HauCl4 solutions were placed on a hot plate while 
constantly stirring to the boiling point at 100°C. 
Then, 0.75 mL sodium citrate solution 1% 
(obtained by dissolving 0.5 gr in 50 mL ionized 
distilled water) is rapidly added into the boiling 
solution under vigorous stirring. Stirring and 
warming were continued until the color of the 
solution changes from light yellow to wine red. 
Then the heating was stopped, but the stirring 
continues for a few more minutes. Due to the low 
volume of the solution, the reaction is rapid. After 
cooling the residual solution containing clearly 
defined gold nanoparticles, distilled water was 
added and placed the container in an oven at 100°C 
to dry the nanoparticles.  
Characterization 
SEM analysis was used to determine the properties 
of nanoparticles. The device used is Hitachi S-4700 
FE-SEM which is a cold field emission high 
resolution scanning electron microscope. This SEM 
permits ultra-high-resolution imaging of thin films 
and semi-conductor materials on exceptionally 
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clean specimens. The S-4700 is configured to detect 
secondary and backscattered electrons as well as 
characteristic X-rays. The system is fully automated 
and operated via menu-driven software.  
The subsequent analysis is X-ray diffraction. 
Philips PW 1390 Diffractometer using CUK 
radiation and Ni-filter was used for crystallographic 
analysis. The X-ray diffractograms were performed 
in the interval 2θ between 10˚ and 80˚, at 2˚/min. 
The X-ray tube was operated at 40 KV and 20 mA. 
We use XRD analysis to determine the 
characteristics of the crystals. The principles of this 
work are based on the radiation of the X-beam to 
the sample at different angles (θ) and the analysis of 
its diffraction or reflection pattern. The maximum 
peak angle indicates the distance between the 
crystal plates and the intensity of each peak 
contains information about how the atoms are 
arranged. The average size, distribution, and 
amount of electric charge of the nanoparticles were 
determined by Zeta Plus, Zeta Particle Size 
Analyzer (Malvern Zetasizer Nano range, UK).  
Results 
After the synthesis process and production, 
determining the properties of the nanoparticles was 
done by SEM study and the results show that the 
distribution of particles is uniform and 
homogeneous. The particles have an average 
diameter of 100-200 nm. The particle structure is 
observed in cubic orbitals which were shown in 
Figure 1. 
 
Figure 1. SEM study shows that the distribution of 
particles is uniform and the particles have an average 
diameter of 100-200 nm and cubic orbitals form. 
In a study with XRD, The powder XRD pattern of 
the GNPs was shown in Figure 2. The major 
diffraction peaks can be indexed as the gold FCC 
phase based on the data of the JCPDS file (JCPDS 
no.04-0784). 
 
Figure 2. The XRD pattern of the GNPs. 
The diffraction peaks of GNPs appeared in 38.1°, 
46.2°, 64.6°, 77.8°, and 82.4°, which can be 
assigned to (111), (200), (220), (311), and (222) 
crystalline plane diffraction peaks of gold, 
respectively. On the nanometer scale metals (most 
of them are FCC) tend to nucleate and grow into 
twinned and multiply twinned particles with their 
surfaces bounded by the lowest-energy (111) facets. 
Other morphologies with less stable facets have 
only been kinetically achieved by adding chemical 
capping reagents to the synthetic systems. Zeta 
potent curves indicated that Z-average was 
137.9 d.nm and in positive charge area. PDI for 
gold-nanoparticle was 0.358 (Figure. 3).  
 
Figure 3. Zeta potent curves with Pdi of the synthesized 
gold nanoparticles. 
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Discussion 
In medical Nano-drug cases, there are two 
important factors, drug release, and drug delivery. 
These two factors can be modified on the 
nanoparticles by reaction non-covalent or covalent 
loading. This manipulation is performed in the 
preparation of drugs to deliver to the cells, with 
high potential. Meanwhile, nanoparticles have high 
flexibility and system performance in this regard (1, 
3, 5). Modification of traditional drugs, including 
research and development of carrier nanoparticles 
for delivery of existing drugs through targeted drug 
delivery systems, nanoparticles are used to reduce 
toxicity, side effects, dosage and improve the 
solubility of insoluble drugs which are applicable 
with the design of suitable nanoparticles (3). The 
second category is new nanoparticles, high efficacy 
drugs, lower toxicity, higher absorption, and better 
targeting, as well as diagnostic drugs based on 
nanoparticles (1, 6). 
In the present study, we have synthesized gold 
nanoparticles with a size of about 100-200 
nanometers using the Turkevich method, which is 
suitable for our intended purposes. In the current 
study, the aim was the production of gold 
nanoparticles as carriers for respiratory system drug 
delivery and especially as an anti-asthma drug 
carrier. After synthesis, produced nanoparticles will 
be used to carry drugs to the bronchi. The smaller 
size of the gold nanoparticles than 50-100 nm 
cannot be effective for our purpose (1, 5) such as, 
protect and carrying drugs (for example peptide 
form drugs), to the lung tissue. Therefore, by 
making slight changes in the details of the work and 
mixing ratios, we were able to synthesize gold 
nanoparticles with a size of about 100-200 nm. The 
size and distribution size has been investigated by 
the Zeta sizer method. Particles smaller than 50-100 
nm are exhaled out of the lungs and are not used to 
treat asthma, and drugs without any useful effect, 
can be returned out by expiration. Particles larger 
than 500 nm are also trapped in the upper airways 
and oropharynx, therefore, cannot enter the airway 
of the lungs, and have no therapeutic effects. 
Three methods have been used to synthesize gold 
nanoparticles; thermal heating (with chemical or 
organic reagents), UV irradiation, and the use of 
ascorbic acid as a reducing agent. In the thermal 
method, a double-walled reactor located in the 
thermostat bath is used, and the necessary heat of 
the reaction is provided. In the UV irradiation 
method, a 5 mm PMMAUV coat is filled with gold 
chloride solution and by adding citrate and stirring, 
irradiation is carried out with a UV at 366nm. In the 
third method, the reduction of gold salt is done by 
ascorbic acid at room temperature. In the recent 
method, by decreasing the temperature, the size and 
quality of the final synthesized particles will 
proceed to the particles with larger diameters and 
irregular shapes. The final study of gold 
nanoparticle synthesis using two methods of 
thermal and UV irradiation yielded similar results. 
These two methods are based on the Turkevich 
protocol, and the only difference is the method of 
heat supply required for the reaction. In this study, 
the Turkevich method has been used, but to reach a 
useful and fit product, the current method has been 
manipulated and modified (3-6). 
In a study by J. Kimling et al, 2006, the synthesis of 
gold nanoparticles from the reduction of gold 
chloride by citrate and ascorbic acid was 
investigated (8). In another study by Harihar Nath 
Verma et al, 2013 the synthesis and characterization 
of gold nanoparticles for therapeutic approaches 
and diagnostic tools for various diseases were 
performed (9). The reduction of gold salt by a 
reducing agent, such as tri-sodium citrate, was 
performed in an aqueous solution. Changes in the 
initial concentration of gold and trisodium citrate 
and temperature have been performed to investigate 
their effect on particle size and distribution. Zeta 
Sizer and SEM have been used to investigate the 
properties of synthesized nanoparticles under 
different conditions. The results show that the 
optimal concentration of gold salt is 20mM and the 
optimal concentration of trisodium citrate is 1.5% 
and the optimum temperature is 97̊C. The gold 
nanoparticles obtained with optimal concentrations 
and temperatures were 15-20 nm in size. Therefore, 
we have to change these parameters to achieve ideal 
parameters for design and anti-asthma drugs carrier. 
In a study conducted by Amir Tabrizi et al, 2009 
the method of reducing gold salt by trisodium 
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citrate was used to synthesize gold nanoparticles 
(10). Changes in the initial concentration of gold 
chloride and trisodium citrate and the rate of mixing 
have been followed to investigate their effect on 
nanoparticle size. In the first step, by keeping the 
initial concentration of tri-sodium citrate at 
0.17 mM and the mixing rate constant at 450 rpm, 
and changing the initial concentration of gold 
chloride from 0.03 mM-0.3 mM, they have reached 
the optimal concentration of gold chloride at 
0.06 mM, which the nanoparticle size 23-120 nm 
has been obtained. A high initial concentration of 
gold chloride leads to the formation of particle 
accumulation and turbidity of the solution. Micron-
sized nanoparticles were also found at low initial 
concentrations of gold chloride. In the second part, 
the changing sodium citrate concentration was 
investigated. In the initial low concentrations of this 
reducing agent, no nanoparticles were formed, 
which indicates the extraordinary importance of 
sodium citrate concentration in the synthesis of gold 
nanoparticles and their sizes. The third part of this 
study included the study of the effect of the mixing 
rate of the synthesis of gold nanoparticles (10). 
Nanoparticle formation was observed at all 
velocities. Higher mixing speeds led to the 
production of very small particles, but the size 
distribution was larger. The optimal speed was 
obtained at 450 rpm. 
Chao Lin et al, 2013 conducted a study using 
nanoparticles synthesized in catalysts to reduce P-
Nitrophenol and examined the effect of nanoparticle 
size on catalytic activity. The gold nanoparticles 
were obtained by NaBH4 gold resuscitation. In this 
work, it has been shown that the size of the gold 
nanoparticles can be changed by adjusting the 
amount of NaBH4 consumed in the synthesis. The 
colloidal solution uses an optimal pH of 5.9 to 
prevent the growth of gold nanoparticles. And also, 
it has been found that the catalytic activity of the 
catalyst depends on the size of the gold 
nanoparticle, and the highest catalytic activity was 
observed at 3.4 nm. Larger size Particles have been 
also synthesized as the initial concentration of 
NaBH4 increased (11). In a study by Zhao Jingyue, 
2015 the synthesis of spherical gold nanoparticles 
in an aqueous solution has been investigated using 
the reduction method. The aim was to obtain 
efficient synthesis methods for the industrial 
production of high-quality gold nanoparticles in 
high quantities. In this work, two chemical 
reduction methods have been used; citrate reducing 
agent and NaBH4 (12). 
In the citrate reduction method, the pH was changed 
and the ionic strength of the environment and the 
presence of other organic matter were controlled, so 
the size and distribution of the particles can be 
controlled. Also, in this method, different amounts 
of gold salt and trisodium citrate have been used to 
achieve different size distribution. The results show 
that in the process of reduction of citrate at 100 ̊C, 
the morphological particles have a more uniform 
and smaller size distribution, although the effect of 
temperature is affected by the initial concentration 
of citrate. In addition, the high concentration of 
gold salt leads to a wider range size distribution, 
larger and more irregular size (1, 3, 8). At 
concentrations above 40 mgAu/100 mL gold 
nanoparticles accumulated strongly. After the 
nanoparticle synthesis process, the dialysis 
membranes were used to reduce impurities, 
including unreacted sodium ions, an excess citrate 
salt, and by-products. When the NaBH4 reducing 
agent was used, synthesis was performed using the 
classical Brust process, which is a two-phase 
method. In this method, a phase transfer factor is 
required. This study shows that the two-phase 
method leads to the synthesis of high-quality 
materials and the distribution of narrow size. In the 
reduction process with NaBH4 reducing agent, 
NaBH4 is a reducing agent and citrate only acts as a 
stabilizer. While in the citrate regeneration method, 
trisodium citrate itself plays both in reducing and 
stabilizing role (7, 10, 12). In the process of 
regenerating with NaBH4, the faster the reaction 
produces the more irregular the gold nanoparticles. 
In a study by Muhammad Iqbal et al. 2015 NaBH4 
was used to reduce gold salt. After obtaining the 
gold nanoparticles, the particle size was calculated 
by both experimental and theoretical methods (13). 
NaBH4 as a reducing agent in different 
concentrations has been added to HAuCl4 0.06 mM 
to investigate the effect of reducing agents on 
particle size and distribution and morphology. The 
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physicochemical aspect of the colloidal system, 
such as particle size and Zeta potential, were 
studied to investigate the effect of colloidal stability 
and the rate of release and interaction of particles 
with cells and the biological environment. The 
Characterizing of particles with TEM indicates that 
the produced nanoparticles were spherical and have 
an average size of less than 30 nm. TEM images 
show that low concentrations of the reducing agent, 
and the particles, are relatively separate and 
homogeneous, but in high concentrations and 
excess of the reducing agent. A small aggregation 
between the particles is observed and the particle 
size has also increased, due to the aggregation of 
particles and excessive reduction of gold salt in the 
presence of excess amounts of NaBH4. The gold 
nanoparticles were synthesized in this study have 
been used for biomedical applications, in vivo and 
in vitro with modified shape and size according to 
our purpose (5, 9, 13). 
In the method of calculating the particle size, 
theoretically, the Mie theory has been used, and the 
optical absorption spectra of the samples have been 
fitted using the Lorentz equation, and the particle 
size has been obtained in good agreement with the 
findings of the standard UV curve and SEM 
analysis. At least, the gold nanoparticles were 
synthesized in this study have been used for 
biomedical application in vivo and in vitro as a drug 
delivery system for treatment and control of asthma .
Depending on the type of work studied, different 
sizes of gold nanoparticles are required, which can 
be obtained by changing the reaction conditions 
such as temperature and, changing the initial 
concentration of the reactants and the type of 
reducing agent, and changing the mixing speed. 
Gold nanoparticle synthesis is a simple, fast, and 
very efficient method with good adaptability and 
can be used in biomedical studies. 
Conclusion 
To achieve the optimal size of gold nanoparticles 
(100-500 nm) as anti-asthma drugs and peptides 
carriers, this modified and manipulated method can 
be useful at low cost and will be done in minimum 
time. The particles small than 100 nm can return 
with exhalation and more than 500 nm will be 
trapped in the upper airways. Therefore, to use 
GNPs for therapeutic purposes in asthma by 
changing the ratio of sodium citrate to gold salt, we 
succeeded in syntheses gold nanoparticles in the 
range of 100-200, which was the ideal size for our 
pharmaceutical and therapeutic purposes. 
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